Study Stopped
Social distancing regulations related to COVID19.
Stress, Anxiety, and Mood Group Therapy
Transdiagnostic Interventions for Emotional Disorders
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to identify cognitive mechanisms that might facilitate treatment response for individuals experiencing depression and/or anxiety. The Stress, Anxiety, and Mood group helps individuals experiencing symptoms of stress, anxiety, and mood by providing concrete coping skills to regulate emotions, to let go of negative thoughts, and build courage to talk to others about tough topics. Groups meet for 8 weeks, with sessions lasting 90 minutes each. In addition to group therapy, you will be asked to complete some computerized and paper and pencil-based tasks. If you are interested in learning more, please contact us at 650-417-2000 ext. 3642 or paloalto.study@gmail.com. All inquiries will be kept strictly confidential.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2019
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedStudy Start
First participant enrolled
March 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedSeptember 18, 2020
September 1, 2020
2.9 years
February 10, 2019
September 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Level of depression as measured by the following questionnaire:
Mood and Anxiety Symptom Questionnaire- Anhedonic Depression subscale
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of intolerance of uncertainty as measured by the following questionnaire:
Intolerance of Uncertainty Questionnaire
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of rumination and reflection as measured by the following questionnaire:
Rumination Reflection Questionnaire
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of anxious arousal as measured by the following questionnaire:
Mood and Anxiety Symptom Questionnaire- Anxious Apprehension subscale
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of anxious apprehension as measured by the following questionnaire:
Penn State Worry Questionnaire
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of alcohol use as measured by the following questionnaire:
Alcohol Use Disorders Identification Test
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of positive and negative emotions as measured by the following questionnaire:
The Positive and Negative Affect Schedule
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of behavioral regulation and metacognition as measured by the following questionnaire:
Behavioral Regulation Index and Metacognition Index
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of trait mood as measured by the following questionnaire:
Trait Meta-Mood Scale.
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of emotion regulation as measured by the following questionnaire:
Emotion Regulation Questionnaire
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of mental imagery as measured by the following questionnaire:
Questionnaire of Mental Imagery
The change from baseline and post-treatment, approximately 8 weeks after baseline
Level of cognitive functioning via neuropsychological testing session
Objective assessment of cognitive strengths and weaknesses
Baseline
Study Arms (1)
Group therapy (Unified Protocol)
EXPERIMENTALParticipants experiencing stress, anxious, and/or depressive symptoms will receive 8 sessions of Unified Protocol for Emotional Disorders lasting for 90 minutes each. Includes psycho-education about (mal)adaptive emotion regulation, cognitive and behavioral tools to reduce symptoms of stress, anxiety, and/or depression.
Interventions
Unified Protocol (UP) is is an 8-week intervention designed to specifically benefit individuals who report co-occurring symptoms of anxiety, stress, and mood by providing them with psychoeducation regarding (mal)adaptive emotion regulation, as well as with skills for effectively responding to stress. UP is based on a cognitive-behavioral framework and uses cognitive and behavioral therapy techniques. Each session of UP group therapy is 90 minutes in duration. Sessions themselves generally include a review of homework and previously discussed concepts, introduction of new material, and in-session discussions/activities.
Eligibility Criteria
You may qualify if:
- Normal color vision
- Ability to travel to Palo Alto University
- Experiencing symptoms of stress, anxiety, and/or depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Palo Alto University
Los Altos, California, 94022, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacie Warren, PhD
Palo Alto University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 10, 2019
First Posted
February 27, 2019
Study Start
March 6, 2019
Primary Completion
February 1, 2022
Study Completion
February 1, 2022
Last Updated
September 18, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share